ShinyBud Corp
Shiny Health & Wellness Corp. operates as a cannabis and pharmacy retailer in Canada. It sells cannabis and accessories, as well as pharmaceutical products and services. The company was formerly known as ShinyBud Corp. The company is headquartered in Kitchener, Canada.
ShinyBud Corp (SNYB) - Net Assets
Latest net assets as of October 2023: CA$-5.08 Million CAD
Based on the latest financial reports, ShinyBud Corp (SNYB) has net assets worth CA$-5.08 Million CAD as of October 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$11.25 Million) and total liabilities (CA$16.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-5.08 Million |
| % of Total Assets | -45.18% |
| Annual Growth Rate | -80.65% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ShinyBud Corp - Net Assets Trend (2022–2023)
This chart illustrates how ShinyBud Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ShinyBud Corp (2022–2023)
The table below shows the annual net assets of ShinyBud Corp from 2022 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-01-31 | CA$3.01 Million | -80.63% |
| 2022-01-31 | CA$15.53 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ShinyBud Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1283124600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (January 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CA$16.23 Million | 539.62% |
| Other Components | CA$4.43 Million | 147.25% |
| Total Equity | CA$3.01 Million | 100.00% |
ShinyBud Corp Competitors by Market Cap
The table below lists competitors of ShinyBud Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MOSAIC
MU:02M
|
$280.83K |
|
SMITHS GROUP - Dusseldorf Stock Exchang
DU:QS2A
|
$281.61K |
|
Argonaut Resources NL
PINK:AGREF
|
$281.70K |
|
YOKOGAWA ELECTRIC
DU:YKE
|
$281.74K |
|
Onfolio Holdings Inc. Warrant
NASDAQ:ONFOW
|
$280.49K |
|
PKNORLEN (PKY1.SG)
STU:PKY1
|
$280.17K |
|
Central African Gold Inc
V:CUCO
|
$279.45K |
|
MARUBENI CORP - Dusseldorf Stock Exchang
DU:MARA
|
$279.43K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ShinyBud Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 15,527,484 to 3,008,438, a change of -12,519,046 (-80.6%).
- Net loss of 12,831,246 reduced equity.
- Other factors increased equity by 312,200.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-12.83 Million | -426.51% |
| Other Changes | CA$312.20K | +10.38% |
| Total Change | CA$- | -80.63% |
Book Value vs Market Value Analysis
This analysis compares ShinyBud Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.12x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-01-31 | CA$1.46 | CA$0.04 | x |
| 2023-01-31 | CA$0.28 | CA$0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ShinyBud Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -426.51%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -43.34%
- • Asset Turnover: 1.31x
- • Equity Multiplier: 7.53x
- Recent ROE (-426.51%) is below the historical average (-231.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -37.30% | -28.05% | 0.58x | 2.29x | CA$-7.34 Million |
| 2023 | -426.51% | -43.34% | 1.31x | 7.53x | CA$-13.13 Million |
Industry Comparison
This section compares ShinyBud Corp's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $30,566,264
- Average return on equity (ROE) among peers: -3.44%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ShinyBud Corp (SNYB) | CA$-5.08 Million | -37.30% | N/A | $280.55K |
| PharmaCorp Rx Inc. (PCRX) | $30.57 Million | -3.44% | 0.15x | $31.02 Million |